Journal article
Can the Addition of NT-proBNP and Glucose Measurements Improve the Prognostication of High-Sensitivity Cardiac Troponin Measurements for Patients with Suspected Acute Coronary Syndrome?
Abstract
Guidelines published in 2021 have supported natriuretic peptide (NP) testing for the prognostication in patients with acute coronary syndrome (ACS) and for the diagnosis of chronic and acute heart failure (HF). Our objective was to determine if the addition of N-terminal pro B-type NP (NT-proBNP) and glucose to high-sensitivity cardiac troponin (hs-cTn) could better identify emergency department (ED) patients with potential ACS at low- and …
Authors
Kavsak PA; Mondoux SE; Hewitt MK; Ainsworth C; Hill S; Worster A
Journal
Journal of Cardiovascular Development and Disease, Vol. 8, No. 9,
Publisher
MDPI
DOI
10.3390/jcdd8090106
ISSN
2308-3425